MisTher: Interest of a Short Early Psychological Care in Women With Miscarriage

Sponsor
Université de Reims Champagne-Ardenne (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05653414
Collaborator
(none)
932
2
40.9

Study Details

Study Description

Brief Summary

Miscarriage is a very common complication of pregnancy, accounting for 15.3% (95% CI 12.5-18.7%) of diagnosed pregnancies. Miscarriage would affect one in ten women during her lifetime. Worldwide, 23 million miscarriages occur annually.

Because of its frequency, miscarriage isoften considered as trivial event by caregivers. Still, miscarriage can be a traumatic event. Literature is consistent on the psychological morbidity associated with miscarriage. Anxiety, depression, post-traumatic stress have been studied in women after miscarriage. Cohort studies and clinical trials suggest that psychological and supportive interventions performed in women after miscarriage may improve women's psychological well-being and reduce miscarriage complications in subsequent pregnancies. However, to date, the literature is considered insufficient on the psychological care of women after a miscarriage.

Condition or Disease Intervention/Treatment Phase
  • Other: short early psychological care associated with encouragement of early support consultation with generalist practitioner or midwife
  • Other: encouragement of early support consultation with generalist practitioner or midwife
N/A

Detailed Description

The aim of the study will be to evaluate the interest of a short early psychological care in women with miscarriage.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
932 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Interest of a Short Early Psychological Care in Women With Miscarriage: a Controlled Randomized Study
Anticipated Study Start Date :
Feb 1, 2023
Anticipated Primary Completion Date :
Aug 1, 2025
Anticipated Study Completion Date :
Jul 1, 2026

Arms and Interventions

Arm Intervention/Treatment
Experimental: "short early psychological care" group

Women with short early psychological care associated with encouragement of early support consultation with generalist practitioner or midwife

Other: short early psychological care associated with encouragement of early support consultation with generalist practitioner or midwife
4 consultations with a psychologist over 2 months maximum

Active Comparator: "control" group

Women with encouragement of early support consultation with generalist practitioner or midwife

Other: encouragement of early support consultation with generalist practitioner or midwife
encouragement of early support consultation with generalist practitioner or midwife

Outcome Measures

Primary Outcome Measures

  1. anxiety [Month 3]

    Anxiety will be evaluated using HADS (Hospital Anxiety and Depression Scale). HADS is a self-administered questionnaire with 7 items evaluating anxiety. Each item is rated on a 4-point scale (ranging from 0 = no not at all, to 3 = yes definitely), for a total score ranging from 0-21. A higher score indicates higher anxiety. Presence of anxiety will be defined by a score greater than or equal to 11.

Secondary Outcome Measures

  1. depression [month 3]

    depression will be evaluated using HADS (Hospital Anxiety and Depression Scale). HADS is a self-administered questionnaire with 7 items evaluating depression. Each item is rated on a 4-point scale (ranging from 0 = no not at all, to 3 = yes definitely), for a total score ranging from 0-21. A higher score indicates higher depression. Presence of depression will be defined by a score greater than or equal to 11.

  2. anxiety [month 6]

    Anxiety will be evaluated using HADS (Hospital Anxiety and Depression Scale). HADS is a self-administered questionnaire with 7 items evaluating anxiety. Each item is rated on a 4-point scale (ranging from 0 = no not at all, to 3 = yes definitely), for a total score ranging from 0-21. A higher score indicates higher anxiety. Presence of anxiety will be defined by a score greater than or equal to 11.

  3. depression [month 6]

    depression will be evaluated using HADS (Hospital Anxiety and Depression Scale). HADS is a self-administered questionnaire with 7 items evaluating depression. Each item is rated on a 4-point scale (ranging from 0 = no not at all, to 3 = yes definitely), for a total score ranging from 0-21. A higher score indicates higher depression. Presence of depression will be defined by a score greater than or equal to 11.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • women with an early miscarriage (defined by a spontaneous termination of pregnancy before the 14th week of amenorrhea)

  • women aged more than 18

  • women agreeing to participate in the study (signing the informed consent form).

Exclusion Criteria:
  • ectopic pregnancy

  • molar pregnancy

  • women with recurrent miscarriages

  • women less than 18

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Université de Reims Champagne-Ardenne

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Université de Reims Champagne-Ardenne
ClinicalTrials.gov Identifier:
NCT05653414
Other Study ID Numbers:
  • 2022_RIPH_003_MisTher
First Posted:
Dec 16, 2022
Last Update Posted:
Dec 20, 2022
Last Verified:
Dec 1, 2022
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Université de Reims Champagne-Ardenne
Additional relevant MeSH terms:

Study Results

No Results Posted as of Dec 20, 2022